Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Gilead Sciences Inc. (GILD)

-NasdaqGS
91.55 Jul 31, 4:00PM EDT
|Pre-Market : 91.07 Down 0.48 (0.52%) 9:18AM EDT - Nasdaq Real Time Price
Prev Close:91.55
Open:N/A
Bid:91.00 x 100
Ask:91.08 x 100
1y Target Est:109.86
Beta:1.01
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:N/A - N/A
52wk Range:55.96 - 94.34
Volume:6,886
Avg Vol (3m):11,556,500
Market Cap:139.71B
P/E (ttm):33.91
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILD 0.00%139.71B
GSK116.18B
PFE183.07B
RHHBY246.82B

Key Statistics

Forward P/E (1 yr):10.09
P/S (ttm):8.01
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.88
Quarterly EPS Est (Sep-14) :1.88
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.47

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback